| Roivant Sciences Ltd. | 3.75M | US$133M | 6.0% |
| Apogee Therapeutics, Inc. | 987K | US$131M | 5.9% |
| Spyre Therapeutics, Inc. | 1.28M | US$114M | 5.1% |
| Xenon Pharmaceuticals Inc. | 1.59M | US$96.3M | 4.4% |
| Erasca, Inc. | 5.25M | US$96.2M | 4.3% |
| Insmed Incorporated | 650K | US$69.3M | 3.1% |
| Praxis Precision Medicines, Inc. | 185K | US$61.9M | 2.8% |
| Oruka Therapeutics, Inc. | 590K | US$56.2M | 2.5% |
| Anaptysbio, Inc. | 826K | US$55.8M | 2.5% |
| Avalo Therapeutics, Inc. | 2.9M | US$53.6M | 2.4% |
| Cytokinetics, Incorporated | 550K | US$46.9M | 2.1% |
| Revolution Medicines, Inc. | 250K | US$46.8M | 2.1% |
| Abivax Sa | 330K | US$44M | 2.0% |
| First Tracks Biotherapeutics, Inc. | 2.03M | US$40.9M | 1.8% |
| Dianthus Therapeutics, Inc. | 400K | US$39M | 1.8% |
| Sutro Biopharma, Inc. | 1.17M | US$38.9M | 1.8% |
| Nuvalent, Inc. | 275K | US$34M | 1.5% |
| Trevi Therapeutics, Inc. | 1.8M | US$33.6M | 1.5% |
| Ovid Therapeutics Inc. | 10.1M | US$27.3M | 1.2% |
| Lexeo Therapeutics, Inc. | 5.81M | US$27M | 1.2% |
| Celldex Therapeutics, Inc. | 700K | US$26M | 1.2% |
| Enliven Therapeutics, Inc. | 500K | US$25.4M | 1.1% |
| Forte Biosciences, Inc. | 1.15M | US$24.3M | 1.1% |
| Nurix Therapeutics, Inc. | 968K | US$23.5M | 1.1% |
| Alto Neuroscience, Inc. | 850K | US$22.4M | 1.0% |
| Madrigal Pharmaceuticals, Inc. | 40,000 | US$21.5M | 0.97% |
| Protagonist Therapeutics, Inc. | 172K | US$21.1M | 0.95% |
| Mineralys Therapeutics, Inc. | 750K | US$20.2M | 0.91% |
| Relay Therapeutics, Inc. | 1.05M | US$19.6M | 0.89% |
| Sagimet Biosciences Inc. - Series A | 2.5M | US$19.3M | 0.87% |
| Jade Biosciences, Inc. | 840K | US$18.7M | 0.84% |
| Cogent Biosciences, Inc. | 450K | US$17.4M | 0.79% |
| Travere Therapeutics, Inc. | 300K | US$17M | 0.77% |
| Cullinan Therapeutics, Inc. | 876K | US$15.9M | 0.72% |
| Savara, Inc. | 2.51M | US$15.5M | 0.70% |
| Ideaya Biosciences, Inc. | 400K | US$14.9M | 0.67% |
| Perspective Therapeutics, Inc. | 4.21M | US$14.4M | 0.65% |
| Odyssey Therapeutics, Inc. | 766K | US$14.3M | 0.65% |
| Helix Acquisition Corp. Iii | 1.25M | US$13.3M | 0.60% |
| Equillium, Inc. | 4.1M | US$13.1M | 0.59% |
| Establishment Labs Holdings Inc. | 148K | US$12.7M | 0.57% |
| Climb Bio, Inc. | 972K | US$12.7M | 0.57% |
| Teva Pharmaceutical Industries Limited | 374K | US$12.7M | 0.57% |
| Veradermics, Incorporated | 100K | US$12.3M | 0.56% |
| Arrowhead Pharmaceuticals, Inc. | 150K | US$12.2M | 0.55% |
| Taysha Gene Therapies, Inc. | 1.75M | US$11.9M | 0.54% |
| Damora Therapeutics, Inc. | 425K | US$11.1M | 0.50% |
| Eupraxia Pharmaceuticals, Inc. | 1.65M | US$10.9M | 0.49% |
| Vera Therapeutics, Inc. | 250K | US$10.7M | 0.48% |
| Korro Bio, Inc. | 707K | US$9.32M | 0.42% |
| Anteris Technologies Global Corp. | 912K | US$8.99M | 0.41% |
| Zura Bio Limited | 1.46M | US$8.64M | 0.39% |
| Ibio, Inc. | 4.01M | US$7.01M | 0.32% |
| Generate Biomedicines, Inc. | 400K | US$6.75M | 0.30% |
| Tyra Biosciences, Inc. | 200K | US$6.39M | 0.29% |
| Sab Biotherapeutics, Inc. | 1.52M | US$5.95M | 0.27% |
| Macrogenics, Inc. | 1.22M | US$5.62M | 0.25% |
| Assembly Biosciences, Inc. | 190K | US$5.22M | 0.24% |
| Rezolute, Inc. | 1M | US$5.2M | 0.24% |
| Precision Biosciences, Inc. | 647K | US$5.08M | 0.23% |
| Hemab Therapeutics Holdings, Inc. | 138K | US$5.07M | 0.23% |
| Viridian Therapeutics, Inc. | 250K | US$4.59M | 0.21% |
| Arrivent Biopharma, Inc. | 125K | US$4.34M | 0.20% |
| Verrica Pharmaceuticals Inc. | 707K | US$4.33M | 0.20% |
| Mbx Biosciences, Inc. | 75,000 | US$4.14M | 0.19% |
| Research Alliance Corporation Iii | 370K | US$3.96M | 0.18% |
| Immunovant, Inc. | 100K | US$3.85M | 0.17% |
| Amanat Acquisition Corp | 375K | US$3.81M | 0.17% |
| Biohaven Ltd. | 250K | US$3.72M | 0.17% |
| Sensei Biotherapeutics, Inc. | 144K | US$3.61M | 0.16% |
| Karyopharm Therapeutics Inc. | 313K | US$3.05M | 0.14% |
| Alector, Inc. | 1.51M | US$3.04M | 0.14% |
| Spyglass Pharma, Inc. | 132K | US$2.93M | 0.13% |
| Crinetics Pharmaceuticals, Inc. | 75,000 | US$2.81M | 0.13% |
| Jatt Ii Acquisition Corp | 200K | US$2.27M | 0.10% |
| Neumora Therapeutics, Inc. | 1.07M | US$1.82M | 0.08% |
| Amylyx Pharmaceuticals, Inc. | 98,999 | US$1.78M | 0.08% |
| Spruce Biosciences, Inc. | 30,000 | US$1.62M | 0.07% |
| Eikon Therapeutics, Inc. | 98,001 | US$1.28M | 0.06% |
| Onkure Therapeutics, Inc. | 241K | US$1.1M | 0.05% |
| X4 Pharmaceuticals, Inc. | 145K | US$677K | 0.03% |
| Boundless Bio, Inc. | 250K | US$625K | 0.03% |
| Lenz Therapeutics, Inc. | 100K | US$568K | 0.03% |
| Q32 Bio Inc. | 27,777 | US$354K | 0.02% |
| Orchestra Biomed Holdings, Inc. | 33,400 | US$144K | <0.01% |
| Nextcure, Inc. | 41,960 | US$67,136 | <0.01% |
| Adagio Medical Holdings, Inc | 80,000 | US$52,128 | <0.01% |
| Bridgebio Pharma, Inc. | 0 | US$0 | 0.00% |
| Corcept Therapeutics Incorporated | 0 | US$0 | 0.00% |
| Engene Holdings Inc. | 0 | US$0 | 0.00% |
| Kezar Life Sciences, Inc. | 0 | US$0 | 0.00% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Ascendis Pharma A/s | 0 | US$0 | 0.00% |